Johnson & Johnson (JNJ)

Track

Over the past 90 days, Johnson & Johnson insiders have engaged in net selling activity totaling approximately $2.41 million. Notable transactions include a sale by EVP Kathryn E. Wengel in June. These divestments occur as the stock trades near its 52-week high, following a positive earnings report in April where the company exceeded EPS expectations.

Recent historical selling signal · Feb 2026

Not featured in screeners

Featured in screeners

Recent historical selling signal · Feb 2026

Not featured in screeners

Ticker: JNJ Exchange: NYS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

30 activity signals detected for Johnson & Johnson

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Johnson & Johnson. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Wengel Kathryn E

EVP, Chief TO and Risk Officer

2 sales — total 4,813,039 USD

Sale 11 Jun 2026

Value US$1,951,303.83 | Price 158.42 | Shares 90,773

Proposed sale 11 Jun 2026

Value US$272,796.06 | Price 312.97 | Shares 40,573

Decker Robert J

VP Corporate Controller

2 sales — total 2,020,141 USD

Sale 27 Feb 2026

Value US$2,349,648.23 | Price 289.21 | Shares 36,434

Proposed sale 27 Feb 2026

Value US$2,771,490.23 | Price 199.30 | Shares 39,181

Schmid Timothy

EVP, WW Chair, MedTech

2 sales — total 649,525 USD

Sale 20 Feb 2026

Value US$324,762.52 | Price 245.66 | Shares 1,322

Proposed sale 20 Feb 2026

Value US$324,762.65 | Price 245.66 | Shares 1,322

Schmid Timothy

EVP, WW Chair, MedTech

3 sales — total 11,055,052 USD

Sale 18 Feb 2026

Value US$2,200,280.94 | Price 244.53 | Shares 8,998

Sale 18 Feb 2026

Value US$3,327,225.00 | Price 244.20 | Shares 13,625

Proposed sale 18 Feb 2026

Value US$5,527,545.94 | Price 244.33 | Shares 22,623

REED JOHN C

EVP, Innovative Medicine, R&D

4 sales — total 26,210,466 USD

Sale 17 Feb 2026

Value US$554,769.00 | Price 243.00 | Shares 2,283

Sale 17 Feb 2026

Value US$7,272,261.00 | Price 243.00 | Shares 29,927

Sale 17 Feb 2026

Value US$5,278,203.00 | Price 243.00 | Shares 21,721

Proposed sale 17 Feb 2026

Value US$13,105,233.00 | Price 243.00 | Shares 53,931

Wolk Joseph J

Exec VP, CFO

5 sales — total 43,535,792 USD

Sale 17 Feb 2026

Value US$6,057,535.48 | Price 242.68 | Shares 24,961

Sale 17 Feb 2026

Value US$8,104,451.50 | Price 242.75 | Shares 33,386

Sale 17 Feb 2026

Value US$2,930,469.42 | Price 242.87 | Shares 12,066

Sale 17 Feb 2026

Value US$4,675,370.59 | Price 242.99 | Shares 19,241

Proposed sale 17 Feb 2026

Value US$21,767,964.99 | Price 242.80 | Shares 89,654

Swanson James D.

EVP, CIO

2 sales — total 9,960,957 USD

Sale 17 Feb 2026

Value US$4,980,446.70 | Price 242.70 | Shares 20,521

Proposed sale 17 Feb 2026

Value US$4,980,510.40 | Price 242.70 | Shares 20,521

Broadhurst Vanessa

EVP, Global Corp Affairs

2 sales — total 3,016,587 USD

Sale 17 Feb 2026

Value US$1,508,287.83 | Price 243.39 | Shares 6,197

Proposed sale 17 Feb 2026

Value US$1,508,299.61 | Price 243.39 | Shares 6,197

Swanson James D.

EVP, CIO

3 sales — total 20,258,558 USD

Sale 13 Feb 2026

Value US$5,408,168.61 | Price 243.71 | Shares 22,191

Sale 13 Feb 2026

Value US$4,721,143.68 | Price 243.76 | Shares 19,368

Proposed sale 13 Feb 2026

Value US$10,129,245.92 | Price 243.73 | Shares 41,559

Forminard Elizabeth

Officer

1 sale — total 1,481,195 USD

Proposed sale 5 Feb 2026

Value US$1,481,195.27 | Price 237.90 | Shares 6,226

Duato Joaquin

CEO and Chairman of the Board

2 sales — total 22,122,893 USD

Sale 26 Jan 2026

Value US$10,804,432.49 | Price 221.48 | Shares 48,782

Sale 26 Jan 2026

Value US$11,318,460.95 | Price 220.99 | Shares 51,218

Joaquin Duato

CEO, Chariman

1 sale — total 22,014,000 USD

Proposed sale 26 Jan 2026

Value US$22,014,000.00 | Price 220.14 | Shares 100,000

MORIKIS JOHN G

1 purchase — total 257,688 USD

Buy 26 Nov 2025

Value US$257,687.50 | Price 206.15 | Shares 1,250

REED JOHN C

EVP, Innovative Medicine, R&D

2 sales — total 8,371,587 USD

Sale 17 Oct 2025

Value US$4,185,793.09 | Price 192.71 | Shares 21,721

Proposed sale 17 Oct 2025

Value US$4,185,794.26 | Price 192.71 | Shares 21,721

Taubert Jennifer L

EVP, WWC. Innovative Medicine

2 sales — total 20,081,787 USD

Sale 4 Sep 2025

Value US$10,040,882.63 | Price 177.81 | Shares 56,471

Proposed sale 4 Sep 2025

Value US$10,040,904.33 | Price 177.81 | Shares 56,471

Forminard Elizabeth

Officer

1 sale — total 1,695,806 USD

Proposed sale 29 Aug 2025

Value US$1,695,805.91 | Price 177.20 | Shares 9,570

Duato Joaquin

CEO and Chairman of the Board

2 sales — total 45,201,379 USD

Sale 22 Aug 2025

Value US$22,548,654.81 | Price 179.21 | Shares 125,824

Proposed sale 22 Aug 2025

Value US$22,652,723.84 | Price 180.04 | Shares 125,824

Wolk Joseph J

Exec VP, CFO

2 sales — total 5,951,142 USD

Sale 15 Aug 2025

Value US$2,975,570.69 | Price 176.91 | Shares 16,820

Proposed sale 15 Aug 2025

Value US$2,975,571.23 | Price 176.91 | Shares 16,820

REED JOHN C

EVP, Innovative Medicine, R&D

2 sales — total 6,259,660 USD

Sale 17 Jul 2025

Value US$3,129,829.56 | Price 163.55 | Shares 19,137

Proposed sale 17 Jul 2025

Value US$3,129,830.51 | Price 163.55 | Shares 19,137

Decker Robert J

VP Corporate Controller

2 sales — total 2,322,004 USD

Sale 25 Feb 2025

Value US$1,160,994.12 | Price 165.88 | Shares 6,999

Proposed sale 25 Feb 2025

Value US$1,161,009.98 | Price 165.88 | Shares 6,999

Schmid Timothy

EVP, WW Chair, MedTech

1 sale — total 62,928 USD

Sale 18 Feb 2025

Value US$62,928.45 | Price 156.15 | Shares 403

Wolk Joseph J

Exec VP, CFO

2 sales — total 4,005,802 USD

Sale 7 Feb 2025

Value US$2,002,878.35 | Price 153.89 | Shares 13,015

Proposed sale 7 Feb 2025

Value US$2,002,923.76 | Price 153.89 | Shares 13,015

WEINBERGER MARK A

1 purchase — total 147,220 USD

Buy 12 Dec 2024

Value US$147,220.00 | Price 147.22 | Shares 1,000

Hait William

Former Officer

1 sale — total 3,858,598 USD

Proposed sale 4 Dec 2024

Value US$3,858,598.43 | Price 149.90 | Shares 25,742

Decker Robert J

VP Corporate Controller

2 sales — total 1,860,226 USD

Sale 30 Aug 2024

Value US$930,113.10 | Price 165.06 | Shares 5,635

Proposed sale 30 Aug 2024

Value US$930,113.10 | Price 165.06 | Shares 5,635

VANESSA BROADHURST

Officer

1 sale — total 1,441,732 USD

Proposed sale 13 Mar 2024

Value US$1,441,731.66 | Price 162.16 | Shares 8,891

Broadhurst Vanessa

EVP, Global Corp Affairs

1 sale — total 1,441,765 USD

Sale 13 Mar 2024

Value US$1,441,764.56 | Price 162.16 | Shares 8,891

Taubert Jennifer L

EVP, WW Chair, Pharmaceuticals

2 sales — total 18,562,497 USD

Sale 9 Feb 2024

Value US$9,281,969.19 | Price 156.27 | Shares 59,397

Proposed sale 9 Feb 2024

Value US$9,280,527.65 | Price 156.25 | Shares 59,397

McEvoy Ashley

Former Officer

1 sale — total 3,851,866 USD

Proposed sale 9 Feb 2024

Value US$3,851,865.88 | Price 156.50 | Shares 24,613

McEvoy Ashley

FORMER OFFICER

1 sale — total 3,885,716 USD

Proposed sale 6 Feb 2024

Value US$3,885,716.16 | Price 157.88 | Shares 24,612

Hait William

See Remarks

2 sales — total 5,056,112 USD

Sale 26 Jul 2023

Value US$2,528,056.00 | Price 172.00 | Shares 14,698

Proposed sale 26 Jul 2023

Value US$2,528,056.00 | Price 172.00 | Shares 14,698

Fasolo Peter

Exec VP, Chief HR Officer

2 sales — total 6,812,160 USD

Sale 25 Jul 2023

Value US$3,406,498.00 | Price 170.32 | Shares 20,000

Proposed sale 25 Jul 2023

Value US$3,405,661.72 | Price 170.28 | Shares 20,000

Wengel Kathryn E

EVP, Chief TO and Risk Officer

2 sales — total 3,988,800 USD

Sale 12 Jun 2023

Value US$1,994,400.00 | Price 160.00 | Shares 12,465

Proposed sale 12 Jun 2023

Value US$1,994,400.00 | Price 160.00 | Shares 12,465

Swanson James D.

See Remarks

1 sale — total 164,199 USD

Sale 6 Mar 2023

Value US$164,199.44 | Price 154.66 | Shares 1,062

Wolk Joseph J

Exec VP, CFO

2 sales — total 2,654,661 USD

Sale 13 Dec 2022

Value US$2,321,755.19 | Price 179.62 | Shares 12,926

Sale 13 Dec 2022

Value US$332,905.72 | Price 179.46 | Shares 1,855

McEvoy Ashley

EVP, WW Chair, MedTech

2 sales — total 12,865,801 USD

Sale 30 Nov 2022

Value US$12,619,271.54 | Price 175.46 | Shares 71,923

Sale 30 Nov 2022

Value US$246,529.22 | Price 176.09 | Shares 1,400

Taubert Jennifer L

EVP, WW Chair, Pharmaceuticals

1 sale — total 13,598,402 USD

Sale 22 Nov 2022

Value US$13,598,401.79 | Price 176.78 | Shares 76,923

Decker Robert J

Controller, CAO

1 sale — total 2,962,400 USD

Sale 18 Nov 2022

Value US$2,962,400.00 | Price 175.00 | Shares 16,928

Wengel Kathryn E

EVP, Chief GSC Officer

1 sale — total 2,845,773 USD

Sale 9 Nov 2022

Value US$2,845,772.97 | Price 173.42 | Shares 16,410

Mongon Thibaut

Exec VP, WW Chair, Consumer

2 sales — total 6,033,305 USD

Sale 4 Nov 2022

Value US$3,132,036.00 | Price 171.22 | Shares 18,293

Sale 4 Nov 2022

Value US$2,901,268.61 | Price 171.14 | Shares 16,953

Fasolo Peter

Exec VP, Chief HR Officer

3 sales — total 265,339 USD

Sale 24 Oct 2022

Value US$90,307.77 | Price 171.36 | Shares 527

Sale 24 Oct 2022

Value US$89,650.05 | Price 170.76 | Shares 525

Sale 24 Oct 2022

Value US$85,381.00 | Price 170.76 | Shares 500

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-12	2026-06-11	S Sale	3.0 Wengel Kathryn E EVP, Chief TO and Risk Officer Officer	90,773 +12.7% 158.42 US$1,951,304	90,773 +12.7%	158.42	US$1,951,304
2026-06-11	2026-06-11	PrS Proposed sale	3.0 Wengel Kathryn E Officer Officer	40,573 312.97 US$272,796	40,573	312.97	US$272,796
2026-03-03	2026-02-27	S Sale	3.3 Decker Robert J VP Corporate Controller Officer	36,434 -40.6% 289.21 US$2,349,648	36,434 -40.6%	289.21	US$2,349,648
2026-02-27	2026-02-27	PrS Proposed sale	3.3 Decker Robert J Officer Officer	4,075 247.87 US$1,010,070	4,075	247.87	US$1,010,070
2026-02-23	2026-02-20	S Sale	3.3 Schmid Timothy EVP, WW Chair, MedTech Officer	1,322 -4.9% 245.66 US$324,763	1,322 -4.9%	245.66	US$324,763
2026-02-20	2026-02-20	PrS Proposed sale	3.3 Schmid Timothy Officer Officer	1,322 245.66 US$324,763	1,322	245.66	US$324,763
2026-02-18	2026-02-18	S Sale	3.3 Schmid Timothy EVP, WW Chair, MedTech Officer	8,998 -25.2% 244.53 US$2,200,281	8,998 -25.2%	244.53	US$2,200,281
2026-02-18	2026-02-18	S Sale	3.3 Schmid Timothy EVP, WW Chair, MedTech Officer	13,625 -33.7% 244.20 US$3,327,225	13,625 -33.7%	244.20	US$3,327,225
2026-02-18	2026-02-18	PrS Proposed sale	3.3 Schmid Timothy Officer Officer	22,623 244.33 US$5,527,546	22,623	244.33	US$5,527,546
2026-02-18	2026-02-17	S Sale	2.6 REED JOHN C EVP, Innovative Medicine, R&D Officer	2,283 -17.6% 243.00 US$554,769	2,283 -17.6%	243.00	US$554,769
2026-02-18	2026-02-17	S Sale	2.6 REED JOHN C EVP, Innovative Medicine, R&D Officer	29,927 -69.8% 243.00 US$7,272,261	29,927 -69.8%	243.00	US$7,272,261
2026-02-18	2026-02-17	S Sale	2.6 REED JOHN C EVP, Innovative Medicine, R&D Officer	21,721 -62.7% 243.00 US$5,278,203	21,721 -62.7%	243.00	US$5,278,203
2026-02-18	2026-02-17	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	24,961 -64.1% 242.68 US$6,057,535	24,961 -64.1%	242.68	US$6,057,535
2026-02-18	2026-02-17	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	33,386 -46.1% 242.75 US$8,104,452	33,386 -46.1%	242.75	US$8,104,452
2026-02-18	2026-02-17	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	12,066 -23.6% 242.87 US$2,930,469	12,066 -23.6%	242.87	US$2,930,469
2026-02-18	2026-02-17	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	19,241 -33.1% 242.99 US$4,675,371	19,241 -33.1%	242.99	US$4,675,371
2026-02-18	2026-02-17	S Sale	2.8 Swanson James D. EVP, CIO Officer	20,521 -44.4% 242.70 US$4,980,447	20,521 -44.4%	242.70	US$4,980,447
2026-02-18	2026-02-17	S Sale	3.4 Broadhurst Vanessa EVP, Global Corp Affairs Officer	6,197 -21.2% 243.39 US$1,508,288	6,197 -21.2%	243.39	US$1,508,288
2026-02-17	2026-02-17	PrS Proposed sale	3.4 Broadhurst Vanessa Officer Officer	6,197 243.39 US$1,508,300	6,197	243.39	US$1,508,300
2026-02-17	2026-02-17	PrS Proposed sale	2.8 Swanson James D. Officer Officer	20,521 242.70 US$4,980,510	20,521	242.70	US$4,980,510
2026-02-17	2026-02-17	PrS Proposed sale	3.2 Wolk Joseph J Officer Officer	89,654 242.80 US$21,767,965	89,654	242.80	US$21,767,965
2026-02-17	2026-02-17	PrS Proposed sale	2.6 REED JOHN C Officer Officer	53,931 243.00 US$13,105,233	53,931	243.00	US$13,105,233
2026-02-18	2026-02-13	S Sale	2.8 Swanson James D. EVP, CIO Officer	22,191 -47.0% 243.71 US$5,408,169	22,191 -47.0%	243.71	US$5,408,169
2026-02-18	2026-02-13	S Sale	2.8 Swanson James D. EVP, CIO Officer	19,368 -43.6% 243.76 US$4,721,144	19,368 -43.6%	243.76	US$4,721,144
2026-02-13	2026-02-13	PrS Proposed sale	2.8 Swanson James D. Officer Officer	41,559 243.73 US$10,129,246	41,559	243.73	US$10,129,246
2026-02-05	2026-02-05	PrS Proposed sale	Forminard Elizabeth Officer Officer	6,226 237.90 US$1,481,195	6,226	237.90	US$1,481,195
2026-01-28	2026-01-26	S Sale	2.0 Duato Joaquin CEO and Chairman of the Board Executive Director	48,782 -61.3% 221.48 US$10,804,432	48,782 -61.3%	221.48	US$10,804,432
2026-01-28	2026-01-26	S Sale	2.0 Duato Joaquin CEO and Chairman of the Board Executive Director	51,218 -39.1% 220.99 US$11,318,461	51,218 -39.1%	220.99	US$11,318,461
2026-01-26	2026-01-26	PrS Proposed sale	2.0 Joaquin Duato CEO, Chariman	100,000 220.14 US$22,014,000	100,000	220.14	US$22,014,000
2025-12-01	2025-11-26	B Purchase	2.7 MORIKIS JOHN G Non-Executive Director	1,250 +208.9% 206.15 US$257,688	1,250 +208.9%	206.15	US$257,688
2025-10-20	2025-10-17	S Sale	2.6 REED JOHN C EVP, Innovative Medicine, R&D Officer	21,721 -67.1% 192.71 US$4,185,793	21,721 -67.1%	192.71	US$4,185,793
2025-10-17	2025-10-17	PrS Proposed sale	2.6 REED JOHN C Officer Officer	21,721 192.71 US$4,185,794	21,721	192.71	US$4,185,794
2025-09-05	2025-09-04	S Sale	2.6 Taubert Jennifer L EVP, WWC. Innovative Medicine Officer	56,471 -24.1% 177.81 US$10,040,883	56,471 -24.1%	177.81	US$10,040,883
2025-09-04	2025-09-04	PrS Proposed sale	2.6 Taubert Jennifer L Officer Officer	56,471 177.81 US$10,040,904	56,471	177.81	US$10,040,904
2025-08-29	2025-08-29	PrS Proposed sale	Forminard Elizabeth Officer Officer	9,570 177.20 US$1,695,806	9,570	177.20	US$1,695,806
2025-08-25	2025-08-22	S Sale	2.0 Duato Joaquin CEO and Chairman of the Board Executive Director	125,824 -31.3% 179.21 US$22,548,655	125,824 -31.3%	179.21	US$22,548,655
2025-08-22	2025-08-22	PrS Proposed sale	2.0 Duato Joaquin Officer; Director Executive Director	125,824 180.04 US$22,652,724	125,824	180.04	US$22,652,724
2025-08-18	2025-08-15	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	16,820 -54.6% 176.91 US$2,975,571	16,820 -54.6%	176.91	US$2,975,571
2025-08-15	2025-08-15	PrS Proposed sale	3.2 Wolk Joseph J Officer Officer	16,820 176.91 US$2,975,571	16,820	176.91	US$2,975,571
2025-07-18	2025-07-17	S Sale	2.6 REED JOHN C EVP, Innovative Medicine, R&D Officer	19,137 -64.2% 163.55 US$3,129,830	19,137 -64.2%	163.55	US$3,129,830
2025-07-17	2025-07-17	PrS Proposed sale	2.6 REED JOHN C Officer Officer	19,137 163.55 US$3,129,831	19,137	163.55	US$3,129,831
2025-02-26	2025-02-25	S Sale	3.3 Decker Robert J VP Corporate Controller Officer	6,999 -25.0% 165.88 US$1,160,994	6,999 -25.0%	165.88	US$1,160,994
2025-02-25	2025-02-25	PrS Proposed sale	3.3 Decker Robert J Officer Officer	6,999 165.88 US$1,161,010	6,999	165.88	US$1,161,010
2025-02-18	2025-02-18	S Sale	3.3 Schmid Timothy EVP, WW Chair, MedTech Officer	403 -2.6% 156.15 US$62,928	403 -2.6%	156.15	US$62,928
2025-02-11	2025-02-07	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	13,015 -100.0% 153.89 US$2,002,878	13,015 -100.0%	153.89	US$2,002,878
2025-02-07	2025-02-07	PrS Proposed sale	3.2 Wolk Joseph J Officer Officer	13,015 153.89 US$2,002,924	13,015	153.89	US$2,002,924
2024-12-12	2024-12-12	B Purchase	2.2 WEINBERGER MARK A Non-Executive Director	1,000 +inf% 147.22 US$147,220	1,000 +inf%	147.22	US$147,220
2024-12-04	2024-12-04	PrS Proposed sale	3.4 Hait William Former Officer Officer	25,742 149.90 US$3,858,598	25,742	149.90	US$3,858,598
2024-09-03	2024-08-30	S Sale	3.3 Decker Robert J VP Corporate Controller Officer	5,635 -22.9% 165.06 US$930,113	5,635 -22.9%	165.06	US$930,113
2024-08-30	2024-08-30	PrS Proposed sale	3.3 Decker Robert J Officer Officer	5,635 165.06 US$930,113	5,635	165.06	US$930,113
2024-03-13	2024-03-13	PrS Proposed sale	3.4 VANESSA BROADHURST Officer Officer	8,891 162.16 US$1,441,732	8,891	162.16	US$1,441,732
2024-03-13	2024-03-13	S Sale	3.4 Broadhurst Vanessa EVP, Global Corp Affairs Officer	8,891 -37.1% 162.16 US$1,441,765	8,891 -37.1%	162.16	US$1,441,765
2024-02-12	2024-02-09	S Sale	2.6 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Officer	59,397 -29.6% 156.27 US$9,281,969	59,397 -29.6%	156.27	US$9,281,969
2024-02-09	2024-02-09	PrS Proposed sale	2.9 McEvoy Ashley Former Officer Officer	24,613 156.50 US$3,851,866	24,613	156.50	US$3,851,866
2024-02-09	2024-02-09	PrS Proposed sale	2.6 Taubert Jennifer L Officer Officer	59,397 156.25 US$9,280,528	59,397	156.25	US$9,280,528
2024-02-06	2024-02-06	PrS Proposed sale	2.9 McEvoy Ashley FORMER OFFICER Officer	24,612 157.88 US$3,885,716	24,612	157.88	US$3,885,716
2023-07-27	2023-07-26	S Sale	3.4 Hait William See Remarks Officer	14,698 -14.3% 172.00 US$2,528,056	14,698 -14.3%	172.00	US$2,528,056
2023-07-26	2023-07-26	PrS Proposed sale	3.4 Hait William Officer Officer	14,698 172.00 US$2,528,056	14,698	172.00	US$2,528,056
2023-07-27	2023-07-25	S Sale	2.6 Fasolo Peter Exec VP, Chief HR Officer Officer	20,000 -16.3% 170.32 US$3,406,498	20,000 -16.3%	170.32	US$3,406,498
2023-07-25	2023-07-25	PrS Proposed sale	2.6 Fasolo Peter Officer Officer	20,000 170.28 US$3,405,662	20,000	170.28	US$3,405,662
2023-06-14	2023-06-12	S Sale	3.0 Wengel Kathryn E EVP, Chief TO and Risk Officer Officer	12,465 -15.9% 160.00 US$1,994,400	12,465 -15.9%	160.00	US$1,994,400
2023-06-12	2023-06-12	PrS Proposed sale	3.0 Wengel Kathryn E Officer Officer	12,465 160.00 US$1,994,400	12,465	160.00	US$1,994,400
2023-03-08	2023-03-06	S Sale	2.8 Swanson James D. See Remarks Officer	1,062 -10.3% 154.66 US$164,199	1,062 -10.3%	154.66	US$164,199
2022-12-15	2022-12-13	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	12,926 -26.5% 179.62 US$2,321,755	12,926 -26.5%	179.62	US$2,321,755
2022-12-15	2022-12-13	S Sale	3.2 Wolk Joseph J Exec VP, CFO Officer	1,855 -3.7% 179.46 US$332,906	1,855 -3.7%	179.46	US$332,906
2022-12-02	2022-11-30	S Sale	2.9 McEvoy Ashley EVP, WW Chair, MedTech Officer	71,923 -63.2% 175.46 US$12,619,272	71,923 -63.2%	175.46	US$12,619,272
2022-12-02	2022-11-30	S Sale	2.9 McEvoy Ashley EVP, WW Chair, MedTech Officer	1,400 -1.2% 176.09 US$246,529	1,400 -1.2%	176.09	US$246,529
2022-11-23	2022-11-22	S Sale	2.6 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Officer	76,923 -37.8% 176.78 US$13,598,402	76,923 -37.8%	176.78	US$13,598,402
2022-11-21	2022-11-18	S Sale	3.3 Decker Robert J Controller, CAO Officer	16,928 -52.2% 175.00 US$2,962,400	16,928 -52.2%	175.00	US$2,962,400
2022-11-10	2022-11-09	S Sale	3.0 Wengel Kathryn E EVP, Chief GSC Officer Officer	16,410 -18.7% 173.42 US$2,845,773	16,410 -18.7%	173.42	US$2,845,773
2022-11-08	2022-11-04	S Sale	3.1 Mongon Thibaut Exec VP, WW Chair, Consumer Officer	18,293 -31.3% 171.22 US$3,132,036	18,293 -31.3%	171.22	US$3,132,036
2022-11-08	2022-11-04	S Sale	3.1 Mongon Thibaut Exec VP, WW Chair, Consumer Officer	16,953 -22.5% 171.14 US$2,901,269	16,953 -22.5%	171.14	US$2,901,269
2022-10-26	2022-10-24	S Sale	2.6 Fasolo Peter Exec VP, Chief HR Officer Officer	527 -0.3% 171.36 US$90,308	527 -0.3%	171.36	US$90,308
2022-10-26	2022-10-24	S Sale	2.6 Fasolo Peter Exec VP, Chief HR Officer Officer	525 -0.3% 170.76 US$89,650	525 -0.3%	170.76	US$89,650
2022-10-26	2022-10-24	S Sale	2.6 Fasolo Peter Exec VP, Chief HR Officer Officer	500 -0.3% 170.76 US$85,381	500 -0.3%	170.76	US$85,381